1. Reporting of Noninferiority and Equivalence Randomized Trials
2. Through the looking glass: understanding non-inferiority
3. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER). Non-inferiority clinical trials to establish effectiveness-guidance for industry. 2016. https://www.fda.gov/downloads/Drugs/Guidances/UCM202140.pdf.
4. Standards of care - Nuffield Bioethics. Nuffield Bioethics. https://nuffieldbioethics.org/report/research-developing-countries-2/standards-care.
5. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat